Letter: elevated liver enzymes and outcome in COVID-19
- PMID: 33016552
- DOI: 10.1111/apt.16010
Letter: elevated liver enzymes and outcome in COVID-19
Comment in
-
Letter: elevated liver enzymes and outcomes in COVID Authors' reply.Aliment Pharmacol Ther. 2020 Oct;52(7):1235-1236. doi: 10.1111/apt.16028. Aliment Pharmacol Ther. 2020. PMID: 33016533 No abstract available.
Comment on
-
Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19.Aliment Pharmacol Ther. 2020 Aug;52(4):584-599. doi: 10.1111/apt.15916. Epub 2020 Jul 8. Aliment Pharmacol Ther. 2020. PMID: 32638436 Free PMC article.
References
REFERENCES
-
- Kulkarni AV, Kumar P, Tevethia HV, et al. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020;52:584-599.
-
- Updates and Data | SECURE Cirrhosis Registry. https://covidcirrhosis.web.unc.edu/updates-and-data/. Accessed July 10, 2020.
-
- Iavarone M, D'Ambrosio R, Soria A, et al. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol. 2020. https://doi.org/10.1016/j.jhep.2020.06.001
-
- Shalimar, Elhence A, Vaishnav M et al. Poor outcomes in patients with cirrhosis and COVID-19. Published online July 7, 2020. https://doi.org/10.21203/rs.3.rs-40220/v1
-
- Ponziani FR, Zompo FD, Nesci A, et al. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2 positive patients. Aliment Pharmacol Ther. 2020. https://doi.org/10.1111/apt.15996
Publication types
LinkOut - more resources
Full Text Sources